# Kalaris Therapeutics, Inc.: Form SCHEDULE 13D, filed Mar 25, 2025

- Company: [Kalaris Therapeutics, Inc.](/companies/klrs.md) (CIK 1754068)
- Form: SCHEDULE 13D
- Filed: 2025-03-25
- Accepted by EDGAR: Mar 25, 2025, 19:40 ET
- Period: not reported
- Accession: 0001415889-25-008979
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1754068/000141588925008979/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1754068/000141588925008979/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1754068/000141588925008979/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-008979. Last ingested by Listed: Oct 26, 2026, 17:31 ET. No prices; not investment advice.